Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B recombinant vaccine
- Development stage
- Unknown
- Lead developer
- Pontificia Universidad Católica de Chile
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A recombinant subunit vaccine used for active immunization against hepatitis B virus (HBV) infection. The vaccine is composed of the hepatitis B surface antigen (HBsAg), which is produced using recombinant DNA technology in yeast cells. It works by stimulating the immune system to produce specific antibodies (anti-HBs) that provide protection against all known subtypes of HBV. This specific entry is associated with a Phase 4 clinical trial conducted by the Pontificia Universidad Catolica de Chile, which evaluates the serological response to an accelerated vaccination schedule (doses at 0, 1, and 2 months) in Haitian immigrants residing in Chile, a population identified as having a high prevalence of HBV exposure.
- Other names
- Hepatitis B recombinant vaccineHBV vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis B recombinant vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B recombinant vaccine.